Stock FBLG FIBROBIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials FibroBiologics, Inc.

Equities

FBLG

US31573L1052

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
11.31 USD +5.21% Intraday chart for FibroBiologics, Inc. -4.15% 0.00%
May. 14 FibroBiologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids CI

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales - - - -
EBITDA - - - -8.842
EBIT 1 -1.169 -1.578 -4.467 -8.889
Operating Margin - - - -
Earnings before Tax (EBT) 1 -1.169 -1.582 -5.121 -16.48
Net income 1 -1.169 -1.582 -5.121 -16.48
Net margin - - - -
EPS 2 -0.1336 -0.1808 -0.1814 -0.6751
Free Cash Flow - - -1.688 3.832
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 2/10/23 2/10/23 5/18/23 2/29/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt - 1.12 5.26 -
Net Cash position - - - 7.28
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - -1.69 3.83
ROE (net income / shareholders' equity) - 245% 194% 1,202%
ROA (Net income/ Total Assets) - - -106% -66.8%
Assets 1 - - 4.853 24.7
Book Value Per Share 2 - -0.0300 -0.1400 0.0400
Cash Flow per Share - 0.0100 0.0800 0.3200
Capex - - - 0.5
Capex / Sales - - - -
Announcement Date 2/10/23 2/10/23 5/18/23 2/29/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
FIBROBIOLOGICS, INC. Stock FibroBiologics, Inc.
0.00% 367M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+10.79% 116B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.65% 106B
BIONTECH SE Stock BioNTech SE
-6.20% 23.89B
ARGENX SE Stock argenx SE
-3.32% 21.58B
GENMAB A/S Stock Genmab A/S
-11.28% 18.96B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.41% 16.33B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-40.50% 16.96B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.64% 14.14B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+31.84% 12.02B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. FBLG Stock
  4. Financials FibroBiologics, Inc.